2190
HKSE:2190
Zylox-Tonbridge Medical Technology Co., Ltd.
- Stock
Last Close
11.14
30/08 08:08
Market Cap
3.51B
Beta: -
Volume Today
584K
Avg: 340.27K
PE Ratio
−24.10
PFCF: −12.34
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 19.47M - | 43.13M 121.49% | 88.26M 104.62% | 151.46M 71.61% | ||
average payables | 3.36M - | 9.36M 178.50% | 12.42M 32.75% | 26.59M 114.00% | ||
average receivables | 1.10M - | |||||
book value per share | 0.51 - | 1.31 156.34% | 10.67 712.86% | 9.37 12.27% | 9.27 1.01% | |
capex per share | -0.13 - | -0.14 8.56% | -0.30 117.89% | -0.44 44.59% | ||
capex to depreciation | -4.34 - | -4.68 7.82% | -6.70 42.95% | -5.53 17.39% | ||
capex to operating cash flow | 0.78 - | 0.55 30.00% | 0.77 40.63% | 1.59 106.34% | ||
capex to revenue | -8.46 - | -1.63 80.68% | -0.50 69.17% | -0.43 13.65% | ||
cash per share | 0.30 - | 0.98 223.30% | 9.94 913.46% | 5.63 43.35% | 4.39 22.10% | |
days of inventory on hand | 975.46 - | 932.87 4.37% | 454.13 51.32% | 534.56 17.71% | 469.59 12.15% | |
days payables outstanding | 207.44 - | 148.14 28.59% | 111.92 24.45% | 48.12 57.00% | 108.51 125.48% | |
days sales outstanding | 0.82 - | |||||
debt to assets | 0.11 - | 0.07 39.78% | 0.00 95.74% | 0.00 48.63% | 0.02 256.98% | |
debt to equity | 0.14 - | 0.08 42.83% | 0.00 96.29% | 0.00 51.31% | 0.02 276.05% | |
dividend yield | ||||||
earnings yield | -0.00 - | -0.01 63.04% | -0.03 407.37% | -0.03 2.82% | -0.02 33.23% | |
enterprise value | 17.28B - | 16.28B 5.80% | 4.60B 71.74% | 2.59B 43.67% | 2.67B 3.02% | |
enterprise value over ebitda | -293.15 - | -177.33 39.51% | -23.02 87.02% | -32.52 41.29% | -19.57 39.83% | |
ev to operating cash flow | -325.55 - | -197.75 39.26% | -39.60 79.97% | -28.39 28.32% | ||
ev to sales | 3.52K - | 589.25 83.24% | 25.87 95.61% | 7.76 70.00% | 5.06 34.78% | |
free cash flow per share | -0.29 - | -0.39 34.65% | -0.70 77.23% | -0.72 2.51% | ||
free cash flow yield | -0.01 - | -0.01 42.90% | -0.03 337.99% | -0.06 82.65% | ||
graham net net | 0.19 - | 0.78 309.05% | 9.69 1,140.90% | 5.33 44.99% | 3.67 31.13% | |
graham number | 1.52 - | 3.01 98.44% | 12.32 308.52% | 8.76 28.85% | 7.07 19.34% | |
income quality | 0.80 - | 0.82 2.87% | 0.58 28.99% | 0.80 38.20% | ||
intangibles to total assets | 0.12 - | 0.04 63.94% | 0.01 78.26% | 0.01 53.58% | 0.00 79.58% | |
interest coverage | -66.61 - | -146.82 120.41% | -710.28 383.77% | -307.74 56.67% | ||
interest debt per share | 0.08 - | 0.11 43.07% | 0.03 69.44% | 0.04 35.18% | 0.16 254.00% | |
inventory turnover | 0.37 - | 0.39 4.57% | 0.80 105.42% | 0.68 15.04% | 0.78 13.83% | |
invested capital | 0.14 - | 0.08 42.83% | 0.00 96.29% | 0.00 51.31% | 0.02 276.05% | |
market cap | 17.31B - | 16.31B 5.78% | 6.01B 63.14% | 3.78B 37.06% | 3.71B 2.07% | |
net current asset value | 83.90M - | 290.87M 246.68% | 2.92B 904.11% | 1.90B 34.84% | 1.39B 27.02% | |
net debt to ebitda | 0.39 - | 0.28 28.59% | 7.05 2,453.78% | 14.94 112.08% | 7.58 49.27% | |
net income per share | -0.20 - | -0.31 53.61% | -0.63 105.31% | -0.36 42.29% | -0.24 34.28% | |
operating cash flow per share | -0.16 - | -0.25 55.08% | -0.39 54.94% | -0.28 29.93% | ||
payables turnover | 1.76 - | 2.46 40.03% | 3.26 32.36% | 7.58 132.56% | 3.36 55.65% | |
receivables turnover | 446.49 - | |||||
research and ddevelopement to revenue | 10.78 - | 2.61 75.82% | 0.94 63.77% | 0.70 26.04% | 0.49 29.23% | |
return on tangible assets | -0.35 - | -0.21 41.80% | -0.06 71.95% | -0.04 35.07% | -0.02 37.68% | |
revenue per share | 0.02 - | 0.09 461.95% | 0.60 606.85% | 1.01 67.44% | 1.61 58.77% | |
roe | -0.39 - | -0.23 40.07% | -0.06 74.74% | -0.04 34.23% | -0.03 33.61% | |
roic | -0.34 - | -0.21 39.19% | -0.06 69.28% | -0.08 17.50% | -0.05 33.07% | |
sales general and administrative to revenue | 3.45 - | 1.12 67.49% | 0.57 49.59% | 0.33 42.12% | 0.22 33.95% | |
shareholders equity per share | 0.51 - | 1.31 156.34% | 10.67 712.86% | 9.37 12.27% | 9.27 1.01% | |
stock based compensation to revenue | 1.55 - | 0.84 45.89% | 0.43 48.79% | 0.26 38.73% | 0.16 38.08% | |
tangible asset value | 141.51M - | 403.49M 185.13% | 3.11B 672.01% | 3.05B 2.14% | 3.04B 0.35% | |
tangible book value per share | 0.44 - | 1.25 185.13% | 10.57 747.50% | 9.23 12.74% | 9.24 0.16% | |
working capital | 91.90M - | 318.51M 246.60% | 2.93B 819.00% | 1.91B 34.73% | 1.40B 26.75% |
All numbers in HKD (except ratios and percentages)